Pay in 4 interest-free payments of $5.61 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Free shipping applies to orders over $35
Intermittent fasting is a method, not a mandate
In this letter, Lilly told clinics that they could no longer promote or sell compounded tirzepatide. Unsurprisingly, this comes in the wake of recent news of Eli Lilly self-announcing that they think tirzepatide will come off shortage very soon. The tirzepatide shortage status, as listed on the FDAs own website, is still not marked Resolved. Any designation as available for a particular dosage strength does not carry any weight under FDA guidance if the overall designation remains Currently in Shortage. We will continue prescribing compounded tirzepatide as usual
Check current Trinity Meds eligibility and program options Compounded GLP-1 vs FDA-Approved Options: What Patients Should Know This distinction comes up frequently in GLP-1 research, so it is worth walking through clearly
US$ 21.55
US$ 26.36
US$ 27.53
US$ 23.84
US$ 24.98
